Statistics for Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)
Total visits
| views | |
|---|---|
| Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab Plus Carboplatin and Etoposide Chemotherapy (Pembrolizumab-Chemotherapy) or Chemotherapy Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC) | 3 |
Total visits per month
| views | |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 3 |
| May 2026 | 0 |
Top country views
| views | |
|---|---|
| Bangladesh | 1 |
| United Kingdom | 1 |
| United States | 1 |
Top city views
| views | |
|---|---|
| Dhaka | 1 |
| Feltham | 1 |